Case report of vancomycin-induced pancytopenia
Rev. Soc. Bras. Med. Trop
;
49(2): 258-259, Mar.-Apr. 2016. tab
Article
in English
| LILACS
| ID: lil-782104
ABSTRACT
Abstract Vancomycin is the first-line agent for the treatment of bacteremia, endocarditis, pneumonia, cellulitis, and osteomyelitis. Pancytopenia is an uncommon adverse effect of vancomycin therapy, with only a few cases of vancomycin-related neutropenia and pancytopenia described in the literature. We describe a case of a 56-year-old man who was diagnosed with chronic paraspinal abscess and started on intravenous vancomycin. He was re-admitted two weeks later with new-onset pancytopenia. Discontinuation of vancomycin resulted in improved cell counts. Physicians should monitor cell counts in patients who are on long-term intravenous vancomycin.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Vancomycin
/
Anti-Bacterial Agents
Limits:
Humans
/
Male
Language:
English
Journal:
Rev. Soc. Bras. Med. Trop
Journal subject:
Tropical Medicine
Year:
2016
Type:
Article
Affiliation country:
United States
Institution/Affiliation country:
Saint Barnabas Hospital/US
Similar
MEDLINE
...
LILACS
LIS